Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus

Med Microbiol Immunol. 1994 May;183(2):105-17. doi: 10.1007/BF00277161.

Abstract

This study describes the properties of an inactivated subunit antigen preparation from varicella-zoster virus (VZV)-infected MRC-5 cells by treatment with detergent and formaldehyde, ultracentrifugation over sucrose and acetone precipitation. The method preserved the antigenicity of VZV proteins and several VZV-specific glycoproteins, while virus DNA was less than 20 pg/250 micrograms protein--a putative vaccine dose. The vaccine was immunogenic in rabbits and stimulated antibodies to the major capsid protein as well as to glycoproteins; an immunoprecipitin was shared with a known immune human serum. The preparation contained no infectious VZV with no evidence of side effects in a rabbit or in five human vaccinees during a follow-up period of 6-10 years.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Antibodies, Viral / biosynthesis
  • Antibodies, Viral / immunology
  • Antigens, Viral / immunology
  • Cell Line
  • Chlorocebus aethiops
  • DNA, Viral / analysis
  • Enzyme-Linked Immunosorbent Assay
  • Herpes Zoster / therapy
  • Herpesvirus 3, Human / genetics
  • Herpesvirus 3, Human / immunology*
  • Humans
  • Neuralgia / etiology
  • Neuralgia / therapy
  • Rabbits
  • Vaccination
  • Vaccines, Inactivated / immunology
  • Vaccines, Synthetic
  • Vero Cells
  • Viral Matrix Proteins / immunology
  • Viral Vaccines / immunology*

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • DNA, Viral
  • Vaccines, Inactivated
  • Vaccines, Synthetic
  • Viral Matrix Proteins
  • Viral Vaccines